| 1 |
Dausset, J. Iso-leuco-anticorps[Iso-leuko-antibodies][J]. Acta Haematol, 1958, 20(1-4):156-166. [in French]
|
| 2 |
Edith Heard. IPD-IMGT/HLA database[DB/OL]. [2023-10-01].
URL
|
| 3 |
Terasaki PI, Cai J. Humoral theory of transplantation: further evidence[J]. Curr Opin Immunol, 2005, 17(5):541-545.
|
| 4 |
Opelz G; Collaborative Transplant Study. Non-HLA transplantation immunity revealed by lymphocytotoxic antibodies[J]. Lancet, 2005, 365(9470):1570-1576.
|
| 5 |
Süsal C, Fichtner A, Tönshoff B, et al. Clinical relevance of HLA antibodies in kidney transplantation: Recent findings from the Collaborative Transplant Study[J]. J Immunol Res, 2017:5619402.
|
| 6 |
See SB, Mantell BS, Clerkin KJ, et al. Profiling non-HLA antibody responses in antibody-mediated rejection following heart transplantation[J]. Am J Transplant, 2020, 20(9):2571-2580.
|
| 7 |
Jackson AM, Wiebe C, Hickey MJ. The role of non-HLA antibodies in solid organ transplantation: a complex deliberation[J]. Curr Opin Organ Transplant, 2020, 25(6):536-542.
|
| 8 |
Kardol-Hoefnagel T, Otten HG. A comprehensive overview of the clinical relevance and treatment options for antibody-mediated rejection associated with non-HLA antibodies[J]. Transplantation, 2021, 105(7):1459-1470.
|
| 9 |
Sorohan BM, Baston C, Tacu D, et al. Non-HLA antibodies in kidney transplantation: immunity and genetic insights[J]. Biomedicines, 2022, 10(7):1506.
|
| 10 |
Baranwal AK, Mehra NK. Major histocompatibility complex class I chain-related A (MICA) molecules: relevance in solid organ transplantation[J]. Frontiers in Immunology, 2017, 8:182
|
| 11 |
Carapito R, Aouadi I, Verniquet M, et al. The MHC class I gene is a histocompatibility antigen in kidney transplantation[J]. Nat Med, 2022, 28(5):989-998.
|
| 12 |
Zou Y, Stastny P, Süsal C, et al. Antibodies against MICA antigens and kidney-transplant rejection[J]. N Engl J Med, 2007, 357(13):1293-1300.
|
| 13 |
Sánchez-Zapardiel E, Castro-Panete MJ, Mancebo E, et al. Early renal graft function deterioration in recipients with preformed anti-MICA antibodies: partial contribution of complement-dependent cytotoxicity[J]. Nephrol Dial Transplant, 2016, 31(1):150-160.
|
| 14 |
Niculite CM, Enciu AM, Hinescu ME. CD 36: Focus on epigenetic and post-transcriptional regulation[J]. Front Genet, 2019, 10:680.
|
| 15 |
Ruan C, Meng Y, Song H. CD36: an emerging therapeutic target for cancer and its molecular mechanisms[J]. J Cancer Res Clin Oncol, 2022, 148(7):1551-1558.
|
| 16 |
Ghosh A, Zhang Li, Chen Kan, et al. Variability of CD36 expression on platelets is determined in part by genetic polymorphisms and can influence platelet function[J]. Blood, 2007, 110 (11): 3643.
|
| 17 |
Okuyama S, Sumi M, Ishikawa R, et al. Successful allogeneic hematopoietic stem cell transplantation in a patient with type I CD36 deficiency: a case study and literature review[J]. Int J Hematol, 2023, 118:656-660.
|
| 18 |
Qiu Z, Wang Y, Zhang Z, et al. Roles of intercellular cell adhesion molecule-1 (ICAM-1) in colorectal cancer: expression, functions, prognosis, tumorigenesis, polymorphisms and therapeutic implications[J]. Front Oncol, 2022, 12:1052672.
|
| 19 |
Nordlander A, Mattsson J, Sundberg B, et al. Novel antibodies to the donor stem cell population CD34＋/VEGFR-2＋ are associated with rejection after hematopoietic stem cell transplantation[J]. Transplantation, 2008, 86(5):686-696.
|
| 20 |
Comoli P, Cioni M, Ray B, et al. Anti-glutathione S-transferase theta 1 antibodies correlate with graft loss in non-sensitized pediatric kidney recipients[J]. Front Med (Lausanne), 2022, 9:1035400.
|
| 21 |
Vale-Silva LA, Markowitz TE, Hochwagen A. SNP-ChIP: a versatile and tag-free method to quantify changes in protein binding across the genome[J]. B BMC Genomics, 2019, 20(1):54.
|
| 22 |
Blann AD, Nadar SK, Lip GY. The adhesion molecule P-selectin and cardiovascular disease[J], Eur Heart J, 2003, 24(24):2166-2179.
|
| 23 |
Jilma B, Marsik C, Kovar F, et al. The single nucleotide polymorphism Ser128Arg in the E-selectin gene is associated with enhanced coagulation during human endotoxemia[J]. Blood, 2005, 105(6):2380-2383.
|
| 24 |
Alzahrani FM, Alhassan JA, Alshehri AM, et al. The impact of SELP gene Thr715Pro polymorphism on sP-selectin level and association with cardiovascular disease in Saudi diabetic patients: a cross-sectional case-control study[J]. Saudi J Biol Sci, 2023, 30(3):103579.
|
| 25 |
Takenaka K, Sakai H, Yamakawa H, et al. Polymorphism of the endoglin gene in patients with intracranial saccular aneurysms[J]. J Neurosurg, 1999, 90(5):935-938.
|
| 26 |
Wu KK, Aleksic N, Ahn C, et al; Atherosclerosis Risk in Communities Study (ARIC) Investigators. Thrombomodulin Ala455Val polymorphism and risk of coronary heart disease[J]. Circulation, 2001, 103(10):1386-1389..
|
| 27 |
Raptis A, Clave E, Mavroudis D, et al. Polymorphism in CD33 and CD34 genes: a source of minor histocompatibility antigens on haemopoietic progenitor cells？[J]. Br J Haematol, 1998, 102(5):1354-1358.
|
| 28 |
Chandra S, Narang R, Sreenivas V, et al. Association of angiotensin II type 1 receptor (A1166C) gene polymorphism and its increased expression in essential hypertension: a case-control study[J]. PLoS One, 2014, 9(7):e101502.
|
| 29 |
Wen YF, Qi B, Liu H, et al. Polymorphisms in the endothelin-1 and endothelin a receptor genes and survival in patients with locoregionally advanced nasopharyngeal carcinoma[J]. Clin Cancer Res, 2011, 17(8):2451-2458.
|
| 30 |
Cai J, Qing X, Tan J, et al. Humoral theory of transplantation: some hot topics[J]. Br Med Bull, 2013, 105:139-155.
|
| 31 |
Abuzeineh M, Aala A, Alasfar S, et al. Angiotensin II receptor 1 antibodies associate with post-transplant focal segmental glomerulosclerosis and proteinuria[J]. BMC Nephrol, 2020, 21(1):253.
|
| 32 |
中国医药生物技术协会移植技术分会，上海市肾脏移植质控中心专家委员会. 肾移植人类白细胞抗原分型和抗体检测专家共识[J]. 中华医学杂志，2022, 102(10): 705-717.
|
| 33 |
Dragun D, Müller DN, Bräsen JH, et al. Angiotensin II type 1-receptor activating antibodies in renal-allograft rejection[J]. N Engl J Med, 2005, 352(6):558-569.
|
| 34 |
Iwata T, Philipovskiy A, Fisher AJ, et al. Anti-type V collagen humoral immunity in lung transplant primary graft dysfunction[J]. J Immunol, 2008, 181(8):5738-5747.
|
| 35 |
Delville M, Lamarthée B, Pagie S, et al. Early acute microvascular kidney transplant rejection in the absence of anti-HLA antibodies is associated with preformed IgG antibodies against diverse glomerular endothelial cell antigens[J]. J Am Soc Nephrol, 2019, 30(4):692-709.
|
| 36 |
Banasik M, Boratyńska M, Kościelska-Kasprzak K, et al. The impact of non-HLA antibodies directed against endothelin-1 type A receptors (ETAR) on early renal transplant outcomes[J]. Transpl Immunol, 2014, 30(1):24-29.
|
| 37 |
Zhang A, Sun D, Thomas D, et al. Humoral risk factors associated to allograft dysfunction after lung transplantation: the alert of non-HLA auto antibody and HLA donor specific antibody (DSA) with non-DSA HLA antibody[J]. J Heart Lung Transplant, 2020, 39(4S): S79-S80.
|
| 38 |
Angaswamy N, Klein C, Tiriveedhi V, et al. Immune responses to collagen-IV and fibronectin in renal transplant recipients with transplant glomerulopathy[J]. Am J Transplant, 2014, 14(3):685-693.
|
| 39 |
Mitate E, Kawano S, Nakao Y, et al. Concurrence of autoantibodies to both laminin γ1 and γ2 subunits in a patient with kidney rejection response[J]. Acta Derm Venereol, 2013, 93(1):114-115.
|
| 40 |
Joosten SA, van Dixhoorn MG, Borrias MC, et al. Antibody response against perlecan and collagen types IV and VI in chronic renal allograft rejection in the rat[J]. Am J Pathol, 2002, 160(4):1301-1310.
|
| 41 |
Barbas AS, Lin L, McRae M, et al. Heparan sulfate is a plasma biomarker of acute cellular allograft rejection[J]. PLoS One, 2018, 13(8):e0200877.
|
| 42 |
Winton HL, Bidwell JL, Armitage WJ. Thrombospondin-1 polymorphisms influence risk of corneal allograft rejection[J]. Invest Ophthalmol Vis Sci, 2014, 55(4):2115-2120.
|
| 43 |
Hachem RR, Tiriveedhi V, Patterson GA, et al. Antibodies to K-α 1 tubulin and collagen V are associated with chronic rejection after lung transplantation[J]. Am J Transplant, 2012, 12(8):2164-2171.
|
| 44 |
Joosten SA, Sijpkens YW, van Ham V, et al. Antibody response against the glomerular basement membrane protein agrin in patients with transplant glomerulopathy[J]. Am J Transplant, 2005, 5(2):383-393.
|
| 45 |
|
| 46 |
Park S, Yang SH, Kim J, et al. Clinical significances of anti-collagen type I and type III antibodies in antibody-mediated rejection[J]. Transpl Int, 2022, 35:10099.
|
| 47 |
Kaczmarek I, Deutsch MA, Sadoni S, et al. Anti-collagen type I antibodies in heart transplant recipients: a pilot study[J]. Transplantation, 84(1):44-49.
|
| 48 |
Armati M, Cattelan S, Guerrieri M, et al. Collagen type IV alpha 5 chain in bronchiolitis obliterans syndrome after lung transplant: the first evidence[J]. Lung, 2023, 201(4): 363-369.
|
| 49 |
Nath DS, Ilias Basha H, Tiriveedhi V, et al. Characterization of immune responses to cardiac self-antigens myosin and vimentin in human cardiac allograft recipients with antibody-mediated rejection and cardiac allograft vasculopathy[J]. J Heart Lung Transplant, 2010, 29(11):1277-1285.
|
| 50 |
Qin Z, Lavingia B, Zou Y, et al. Antibodies against nucleolin in recipients of organ transplants[J]. Transplantation, 2011, 92(7):829-835.
|
| 51 |
Álvarez-Márqueza A, Isabel Aguileraa, Rosa María Blancob, et al. Positive association of anticytoskeletal endothelial cell antibodies and cardiac allograft rejection[J]. Hum Immunol, 2008, 69(3):143-148.
|
| 52 |
Rampersad C, Shaw J, Gibson IW, et al. Early antibody-mediated kidney transplant rejection associated with anti-vimentin antibodies: a case report[J]. Am J Kidney Dis, 2020, 75(1):138-143.
|
| 53 |
Inui A, Sogo T, Komatsu H, et al. Antibodies against cytokeratin 8/18 in a patient with de novo autoimmune hepatitis after living-donor liver transplantation[J]. Liver Transpl, 2005, 11(5):504-507.
|
| 54 |
Yun JJ, Fischbein MP, Whiting D, et al. The role of MIG/CXCL9 in cardiac allograft vasculopathy[J]. Am J Pathol, 2002, 161(4):1307-1313.
|
| 55 |
Sigdel TK, Li L, Tran TQ, et al. Non-HLA antibodies to immunogenic epitopes predict the evolution of chronic renal allograft injury[J]. J Am Soc Nephrol, 2012, 23(4):750-763.
|
| 56 |
Wood KL, Nunley DR, Moffatt-Bruce S, et al. The role of heat shock protein 27 in bronchiolitis obliterans syndrome after lung transplantation[J]. J Heart Lung Transplant, 2010, 29(7):786-791.
|
| 57 |
Merkel PA, Lebo T, Knight V. Functional analysis of anti-cytokine autoantibodies using flow cytometry[J]. Front Immunol, 2019, 10:1517.
|
| 58 |
Loupy A, Mark Haas, Candice Roufosse, et al. The Banff 2019 Kidney Meeting Report (I): Updates on and clarification of criteria for T cell- and antibody-mediated rejection[J]. Am J Transplant, 2020, 20(9):2318-2331.
|